Your browser doesn't support javascript.
loading
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.
Lindsay, Colin R; Shaw, Emily C; Blackhall, Fiona; Blyth, Kevin G; Brenton, James D; Chaturvedi, Anshuman; Clarke, Noel; Dick, Craig; Evans, Thomas R J; Hall, Geoff; Hanby, Andrew M; Harrison, David J; Johnston, Stephen R D; Mason, Malcolm D; Morton, Dion; Newton-Bishop, Julia; Nicholson, Andrew G; Oien, Karin A; Popat, Sanjay; Rassl, Doris; Sharpe, Rowena; Taniere, Phillipe; Walker, Ian; Wallace, William A; West, Nicholas P; Butler, Rachel; Gonzalez de Castro, David; Griffiths, Mike; Johnson, Peter W M.
  • Lindsay CR; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Shaw EC; Manchester Experimental Cancer Medicine Centre, Manchester, UK.
  • Blackhall F; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.
  • Blyth KG; Cancer Research UK, London, UK.
  • Brenton JD; Southampton Experimental Cancer Medicine Centre, Southampton, UK.
  • Chaturvedi A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Clarke N; Manchester Experimental Cancer Medicine Centre, Manchester, UK.
  • Dick C; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.
  • Evans TRJ; Glasgow Experimental Cancer Medicine Centre, Glasgow, UK.
  • Hall G; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
  • Hanby AM; Institute ofInfection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
  • Harrison DJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Johnston SRD; Cancer Research UK Cambridge Centre and Cambridge Experimental Cancer Medicine Centre, Cambridge, UK.
  • Mason MD; Addenbrooke'sHospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
  • Morton D; Department of Histopathology, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.
  • Newton-Bishop J; Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.
  • Nicholson AG; Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.
  • Oien KA; Glasgow Experimental Cancer Medicine Centre, Glasgow, UK.
  • Popat S; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
  • Rassl D; Glasgow Experimental Cancer Medicine Centre, Glasgow, UK.
  • Sharpe R; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Taniere P; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Walker I; Leeds Experimental Cancer Medicine Centre, Leeds, UK.
  • Wallace WA; St James's University Hospital, Cancer Research UK Clinical Cancer Centre, Leeds, UK.
  • West NP; Leeds Experimental Cancer Medicine Centre, Leeds, UK.
  • Butler R; Department of Cellular Pathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Gonzalez de Castro D; School of Medicine, University of Leeds, Leeds, UK.
  • Griffiths M; Department of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
  • Johnson PWM; School of Medicine, University of St Andrews, St Andrews, UK.
ESMO Open ; 3(6): e000408, 2018.
Article en En | MEDLINE | ID: mdl-30233821